WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO1999004788) AQUEOUS COMPOSITIONS COMPRISING RANITIDINE AND LCMT SUCROSE
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/1999/004788    International Application No.:    PCT/EP1998/004503
Publication Date: 04.02.1999 International Filing Date: 22.07.1998
Chapter 2 Demand Filed:    22.01.1999    
IPC:
A61K 9/00 (2006.01), A61K 31/341 (2006.01), A61K 47/26 (2006.01)
Applicants: GLAXO GROUP LIMITED [GB/GB]; Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB) (AL, AM, AT, AU, AZ, BA, BB, BE, BF, BG, BJ, BR, BY, CA, CF, CG, CH, CI, CM, CN, CU, CY, CZ, DE, DK, EE, ES, FI, FR, GA, GB, GE, GH, GM, GN, GR, GW, HR, HU, ID, IE, IL, IS, IT, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MC, MD, MG, MK, ML, MN, MR, MW, MX, NE, NL, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, SN, SZ, TD, TG, TJ, TM, TR, TT, UA, UG, UZ, VN, YU, ZW only).
CARICOFE, Ralph, Boyer [US/US]; (US) (For US Only)
Inventors: CARICOFE, Ralph, Boyer; (US)
Agent: REED, Michael, A.; Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB).
DOLTON, Peter, I.; Glaxo Wellcome plc, Glaxo Wellcome House, Berkeley Avenue, Greenford, Middlesex UB6 0NN (GB)
Priority Data:
9715423.1 23.07.1997 GB
Title (EN) AQUEOUS COMPOSITIONS COMPRISING RANITIDINE AND LCMT SUCROSE
(FR) COMPOSITIONS AQUEUSES CONTENANT DE LA RANITIDINE ET DU SACCHAROSE LCMT
Abstract: front page image
(EN)The invention relates to an aqueous pharmaceutical composition for oral administration comprising ranitidine, or a pharmaceutically acceptable salt thereof, characterised in that the composition contains low colour, metal, turbidity (LCMT) sucrose.
(FR)L'invention porte sur une composition pharmaceutique aqueuse à administration orale, comprenant de la ranitidine, ou un sel pharmaceutiquement acceptable de cette dernière. La composition est caractérisée en ce qu'elle contient du saccharose LCMT (low colour, metal, turbidity: à coloration, métal, turbidité faibles).
Designated States: AL, AM, AT, AU, AZ, BA, BB, BG, BR, BY, CA, CH, CN, CU, CZ, DE, DK, EE, ES, FI, GB, GE, GH, GM, HR, HU, ID, IL, IS, JP, KE, KG, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MD, MG, MK, MN, MW, MX, NO, NZ, PL, PT, RO, RU, SD, SE, SG, SI, SK, SL, TJ, TM, TR, TT, UA, UG, US, UZ, VN, YU, ZW.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, SD, SZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)